In this latest Texas Tech HSC expert column, Dr. Mohamad Sidani looks at the importance of thyroid health on the metabolism.

The Osteoporosis Therapeutics market value was US$ $$ billion in 2021. The Osteoporosis Therapeutics market value is forecast to reach US$ $$ billion by 2031, growing at a compound annual growth rate ...

Ascendis Pharma A/S (Nasdaq: ASND) today announced that YORVIPATH® (palopegteriparatide; developed as TransCon PTH) is now ...

YORVIPATH is a prodrug of parathyroid hormone, administered once-daily, designed to provide continuous exposure to active PTH over the 24-hour dosing period. Published first on TheFly – the ultimate ...

YORVIPATH is a prodrug of parathyroid hormone (PTH [1-34]), administered once-daily, designed to provide continuous exposure to active PTH over the 24-hour dosing period. It is the first and only ...

Eneboparatide is a recombinant peptide commercialized by AstraZeneca, with a leading Phase III program in Hypoparathyroidism.

The following is a summary of “Development of patient-specific 3D anatomical models in minimally invasive parathyroidectomy,” ...

Some 10 years later, it was Conan O'Brien's turn. The US comedian and talkshow host appeared on New Zealand's prime-time ...

A study published in the Journal of Clinical Endocrinology and Metabolism  explores the relationship between weight loss, vitamin D status, | Cardiology ...

Endocrine surgeons primarily focus on the thyroid, parathyroid, and adrenal glands. For the thyroid, their work often ...

Orsini has been selected by Ascendis Pharma as a specialty pharmacy partner for YORVIPATH® (palopegteriparatide), an ...

PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to announce it is partnering with Ascendis Pharma for the distribution of ...